Sesodex 200 μg Concentrate for solution for infusion
PDF Leaflet Revision Date: 7 February 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Sedation in ICU and monitored anaesthesia care.
Dosage (summary)
Loading: 1 mcg/kg over 10 mins; Maintenance: 0.2-0.7 mcg/kg/hr.
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Safety not established in pregnancy or breastfeeding.
Key Drug Interactions
- Enhanced effects with anaesthetics, sedatives, opioids.
Contraindications
- Hypersensitivity to dexmedetomidine
- Sepsis
- Unstable trauma
- Hypovolaemia
- Heart block
- Uncontrolled cardiac failure
- Imminent hepatic failure
Common side effects
- Hypotension
- Bradycardia
- Nausea
- Dry mouth
- Hypoxia
Counselling Points
- Avoid driving or operating machinery for 24 hours post-sedation.
- Monitor for signs of bradycardia or hypotension.
- Inform healthcare provider of all medications.
Serious warnings
- Risk of respiratory depression.
- Continuous monitoring required.
- Not suitable for deep sedation.
Important Disclaimer
The Sesodex 200 μg Concentrate for solution for infusion professional information leaflet below is the property of Austell Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
